MedTrace Logo

SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy

NCT00403078 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21008

Last updated 2020-08-10

No results posted yet for this study

Summary

The primary objective of this study is to assess the outcomes of stenting with distal protection in the treatment of obstructive carotid artery disease. The devices to be utilized are the Cordis PRECISE® Nitinol Stent Systems (5.5F and 6F) and the Cordis ANGIOGUARD™ XP Emboli Capture Guidewire (ECGW).

Conditions

  • Carotid Artery Disease

Sponsors & Collaborators

  • Cordis Corporation

    lead INDUSTRY

Principal Investigators

  • Rajesh Dave, MD · Harrisburg Hospital, 2808 Old Post Rd., Harrisburg, PA 17110

  • Robert Hibbard, MD · Bryan LGH Heart Institute, 1500 South 48th St, Suite 400, Lincoln, NE 68506

  • Douglas Massop, MD · Iowa Clinic-Heart and Vascular Care, 5950 University Ave, West Des Moines, IA 50266

  • Christopher Metzger, MD · The Heart Center, PC, 2050 Meadowview Parkway, Kingsport, TN 37660

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2014-07-31
Completion
2014-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00403078 on ClinicalTrials.gov